Skip to main content
Circassia's COPD candidate gets FDA nod
4/26/2019

Circassia's Duaklir, which delivers aclidinium bromide/formoterol, has been approved by the FDA as a treatment for patients with chronic obstructive pulmonary disease. It is expected to be launched in the coming months.

Full Story: